<DOC>
	<DOCNO>NCT02249312</DOCNO>
	<brief_summary>Study evaluate anti-inflammatory effect BIIL 284 BS compare placebo patient asthma</brief_summary>
	<brief_title>The Effect BIIL 284 BS Induced-sputum Variables Patients With Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Written inform consent sign date prior participation study Males female age 18 65 year . Female patient child bear potential participate study . Female patient eligible participate surgically sterilize two year post menopausal . Women enter trial pregnancy test participation trial . Testing do visit 1 visit 5 A documented diagnosis asthma define American thoracic society i.e. , episodic wheezing , chest tightness , cough and/or shortness breath least partially relieved bronchodilator medication . No hospital admission last eight week treatment asthma ; requirement steroid therapy ( systemic inhale ) previous four week , nedocromil sodium sodium cromoglycate previous two week ; asthma therapy stable limited intermittent use inhaled Î²2agonists anticholinergic required basis , occasional use antihistamine . Predicted equation force expiratory volume one second ( FEV1 ) Caucasians African Americans Morris et . al . Glindmeyer et . al . At visit 2 , 3 , 5 , immediately prior induced sputum test , follow albuterol administration , patient 's FEV1 must 60 % predict The presence , least , 25 % neutrophil induce sputum screen visit 2 ( requirement refers neutrophils percentage exclusive squamous cell ) Ability produce adequate induce sputum sample ( visit 2 ) define : Volume &gt; 1 ml , squamous cell &lt; 80 % ability tolerate procedure least 4 minute bronchoconstriction ( fall FEV1 &gt; 20 % ) Patients PC20 methacholine &lt; = 8 mg/ml determine visit 1 Nonsmokers ( patient never smoke ) exsmokers least one year smoking history , great five packyears ( 1 pack year = 20 cigarette per day 1 year ) Ability train proper use peak flow meter ( Mini Wright peak flow meter , Clement Clarke , Inc. ) perform record technically satisfactory pulmonary function test Willing attend outpatient clinic regular basis undergo three induce sputum challenge confine investigational unit two hour Ability comply concomitant therapy restriction Patients prescription drug therapy specifically asthma hay fever . Over counter ( O.T.C . ) drug must discontinue least two week prior participation study . If O.T.C . medication need patient throughout study , investigator call clinical monitor review casebycase basis Patients evidence clinically relevant concomitant disease base upon complete medical history , full physical examination , chest xray ( do previous 6 month ) , electrocardiogram ( ECG ) clinical laboratory test . These test indicate patient healthy except change relate asthma atopy ( e.g. , eosinophilia base total eosinophil count ) . Patient may history allergic rhinitis urticaria . The following laboratory parameter must within normal range , , document investigator clinically relevant : Routine urinalysis , Complete blood cell ( CBC ) ( exclude White blood cell ( WBC ) ) , Na , K , Ca , Cl , Gammaglutamyltransferase ( GGT ) , Lactic dehydrogenase ( LDH ) , bicarbonate , inorganic phosphorus , glucose , uric acid , triglyceride , total protein , albumin cholesterol . The following test may outside normal range extent indication : Test ; Liver function test : serum glutamic oxaloacetic transaminase / aspartate aminotransferase ( SGOT/AST ) , serum glutamic pyruvic transaminase / alanine transaminase ( SGPT/ALT ) , total bilirubin ( patient isolate raise bilirubin diagnosis `` suspect Gilbert 's syndrome '' accept effect high carbohydrate meal bilirubin level determine ) alkaline phosphatase cut exclusion 10 % &gt; ULN ( upper limit normal range measure laboratory ) Test b ; Hematology : WBC cut exclusion &lt; 3.80 x 10**9 /L , neutrophils cut exclusion &lt; 2.00 x 10**9 /L , platelet cut exclusion &lt; 100 x 10**9 /L , hemoglobin cut exclusion &lt; 12 g/dL Test c ; urea nitrogen creatinine cut exclusion 10 % &gt; ULN Exclusion criterion : Viral respiratory tract infection , respiratory tract infection asthma exacerbation within six week precede study , hospitalize asthma last eight week Evidence relevant concomitant disease base complete medical history , full physical examination clinical laboratory test Known drug alcohol dependence ( absence dependency 10 year ) , history significant allergic reaction drug sensitivity aspirin Use investigational new drug precede month six half life ( whichever great ) prior first screen visit 1 Donate blood precede month visit 1 Patients receive hyposensitization therapy stable dose last three month visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>